Log in to save to my catalogue

854 HPK1 inhibition relieves suppression downstream of TCR activation to drive enhanced cytokine pro...

854 HPK1 inhibition relieves suppression downstream of TCR activation to drive enhanced cytokine pro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2840756543

854 HPK1 inhibition relieves suppression downstream of TCR activation to drive enhanced cytokine production and antigen-specific killing, an effect that is further enhanced by immune checkpoint blockade

About this item

Full title

854 HPK1 inhibition relieves suppression downstream of TCR activation to drive enhanced cytokine production and antigen-specific killing, an effect that is further enhanced by immune checkpoint blockade

Publisher

London: BMJ Publishing Group LTD

Journal title

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A893-A893

Language

English

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundT cell activation is critical in the initiation and potentiation of anti-tumor immune responses. Hematopoietic Progenitor Kinase 1 (HPK1) is a member of the MAP4K family whose activity restrains T cell activation through phosphorylation of SLP-76 (pSLP-76) at Serine 376, leading to disassembly of the TCR complex. Mouse genetic deletion an...

Alternative Titles

Full title

854 HPK1 inhibition relieves suppression downstream of TCR activation to drive enhanced cytokine production and antigen-specific killing, an effect that is further enhanced by immune checkpoint blockade

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2840756543

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2840756543

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2022-SITC2022.0854

How to access this item